These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25546023)

  • 1. Preconception and pregnancy management of women with diabetic nephropathy on angiotensin converting enzyme inhibitors.
    Podymow T; Joseph G
    Clin Nephrol; 2015 Feb; 83(2):73-9. PubMed ID: 25546023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
    Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.
    How HY; Sibai BM
    J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy.
    Bar J; Chen R; Schoenfeld A; Orvieto R; Yahav J; Ben-Rafael Z; Hod M
    J Pediatr Endocrinol Metab; 1999; 12(5):659-65. PubMed ID: 10703538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy and pregnancy.
    Landon MB
    Clin Obstet Gynecol; 2007 Dec; 50(4):998-1006. PubMed ID: 17982343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study.
    Li DK; Yang C; Andrade S; Tavares V; Ferber JR
    BMJ; 2011 Oct; 343():d5931. PubMed ID: 22010128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic nephropathy and ACE inhibitors].
    Amann B
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i83-7. PubMed ID: 16598556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1605-7. PubMed ID: 16901062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
    Pucci M; Sarween N; Knox E; Lipkin G; Martin U
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major congenital malformations after first-trimester exposure to ACE inhibitors.
    Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
    N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.
    MacKinnon M; Shurraw S; Akbari A; Knoll GA; Jaffey J; Clark HD
    Am J Kidney Dis; 2006 Jul; 48(1):8-20. PubMed ID: 16797382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in renal outcomes with ACE inhibitors in type 1 and type 2 diabetic patients: possible explanations.
    Jerums G
    Miner Electrolyte Metab; 1998; 24(6):423-37. PubMed ID: 9930382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.